Teva, Sun Pharma Shipments Surge as Cartel Case Looms November 27, 2019 Teva and Sun Pharmaceuticals have been in discussions with the U.S. Department of Justice to settle a price-fixing probe into generic pharmaceutical pricing. The stakes are high given convictions could prevent firms from working with Medicare / Medicaid according to Bloomberg. U.S. seaborne im... Read more →
Dr Reddy’s Ready for Growth As Imports Surge After Quiet Quarter October 30, 2018 Generic drug manufacturer Dr. Reddy’s Labs reported third quarter revenues in the U.S. that fell by 0.3% on a year earlier. The company cites declining prices as a major factor, which can also be seen in the 13.6% drop in average import values per gram for U.S. imports of all pharmaceuticals. ... Read more →
Could Croatia Pay The Price For Netanyahu’s Teva Request? December 14, 2017 Teva Pharma has launched a significant restructuring program, designed to cut 19% from its cost base after significant price deflation and sector-wide profit warnings from August. That will include “optimization” of its generic drug portfolio, including price rises and product terminations in ... Read more →
United States
中文